Facebook
X
LinkedIn
Forward
Let's Take a BiTE Out of CRS and Neurotoxicity - SPOC
Webinar InformationWebinar Description Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities. Learning Objectives
|
Webinar DocumentsHandouts |
Webinar RegistrationYou must have an account and be logged in to register. Please contact us with any questions at [email protected] or (919) 445–1000. DisclaimerThe views expressed herein are those of the presenter, they do not necessarily reflect the views of the contracted organization, department, School of Medicine, nor the University of North Carolina at Chapel Hill. |
You may also be interested in
 | The mission of Advanced Practice Provider (APP) Grand Rounds webinar is to provide a forum for high-quality hematology/oncology-based content. The purpose of this monthly series is to share expertise and create a structured network for our vast community by promoting professional development, creating opportunities for collaboration, and using evidence-based education to increase knowledge and skills to foster ongoing quality patient care. These webinars provide FREE continuing education credit. |
 | Bejal Kikani, MSN, FNP-BC, WHNP-BC Nurse Practitioner |
This Non-Credit Course does not have accreditation. It only offers general participation certificates. |
Available Credit
- 1.00 Participation